E-mini IPOX® 100 U.S. Index Futures
Capture the Dynamics of U.S. IPOs and Spin-offs
Key Information:
Contract Unit: $10 x IPOX 100 U.S. Index
Trading Hours: Available nearly 24 hours a day on CME Globex
Minimum Price Fluctuation: 0.25 index points ($2.50)
Settlement Method: Financially settled
Listed Contracts: Quarterly contracts for 5 consecutive quarters
Why Trade IPOX Futures?
Capitalize on the unique growth characteristics of newly public companies
Diversify your portfolio with exposure to innovative and emerging companies
Implement sophisticated trading strategies around IPO events and performance
Proxy exposure to the strongly linked Pre-IPO Market and highly liquid hedging opportunities.
The IPOX® 100 U.S. Index shows high correlation to private market indexes, e.g. Morningstar Pitchbook Indexes
The E-mini IPOX® 100 U.S. Index Futures offer a unique opportunity to trade on the growth and innovation in the U.S. Initial Public Offering (IPO) market. Launched by CME Group in collaboration with IPOX Schuster LLC, these futures contracts allow investors to capture the return dynamics of IPOs, spin-offs and IPO M&A actions - ideal for market participants who seek a liquid highly correlated asset to hedge pre-IPO exposure.
Interested to become a Market Maker for IPOX® Futures?
Contact us for free data arrangements at info@ipox.com
Benefits:
Access to IPO Performance: Gain exposure to a diverse portfolio of newly public companies and spin-offs.
Risk Management: Hedge your exposure to the IPO sector or individual IPO stocks.
Trading Flexibility: Trade around the clock on CME Globex platform.
Capital Efficiency: Benefit from the leverage and capital efficiencies of futures contracts.
About the IPOX 100 U.S. Index:
The underlying IPOX® 100 U.S. Index, developed by IPOX Schuster LLC, tracks the performance of the 100 largest, typically best-performing, and most liquid U.S. IPOs, spin-offs and IPO M&A corporate actions. The index provides a comprehensive and rules-based approach to measuring the average performance of U.S. IPOs during their first four years of trading.
Contact info@ipox.com for more information